what is glp-1 made from Medications: Everything You Need to Know Evolution of GLP‐1 Receptor Agonists
Description
In Q1 2025, diabetes and obesity drugs have overtaken oncology and autoimmune treatments to become the largest contributors to blockbuster salesreflecting the evolving pharmaceutical market cycle
However, most people achieving 12-17% weight loss with Semaglutide experience significant health improvements and may not need to switch
Some insurers previously limited GLP-1 coverage for obesity, but Medicare is partially expanding access, though coverage does not reach all who want it
Concerns for Diabetic Patients While these drugs benefit diabetic patients by managing blood sugar levels, the risk of gastroparesis is particularly concerning for this population
Non-canonical amino acids are difficult to reliably incorporate in a recombinant expression system
